Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    An Enquiry

    Left Arrow
    Right Arrow

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Helex is pioneering non-viral, targeted delivery and genome editing for kidney diseases, developing first-in-class genetic medicines for renal indications. Using its proprietary kidney-tropic lipid nanoparticle delivery system and Epic-Cure™ 3D genome-based drug design platform, Helex is building a strong pipeline of precise and scalable therapeutics. Its lead program targets Autosomal Dominant Polycystic Kidney Disease, off...
    Helex is pioneering non-viral, targeted delivery and genome editing for kidney diseases, developing first-in-class genetic medicines for renal indications. Using its proprietary kidney-tropic lipid nanoparticle delivery system and Epic-Cure™ 3D genome-based drug design platform, Helex is building a strong pipeline of precise and scalable therapeutics. Its lead program targets Autosomal Dominant Polycystic Kidney Disease, offering a mutation-agnostic, one-time treatment for over 4 million patients worldwide.

    List your booth number for exhibitions, ask us

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.